central-nervous-system-2016_posters-accepted-abstracts

37 / 42

Page 96
CNS 2016
December 05-07, 2016
Volume 7, Issue 5(Suppl) J Neurol Neurophysiol
ISSN: 2155-9562 JNN, an open access journal
conferenceseries .com
December 05-07, 2016 Dubai, UAE
2nd International Conference on
Central Nervous System Disorders & Therapeutics
J Neurol Neurophysiol 2016, 7:5(Suppl)
Changes inmyelopathic signs and functional outcome after cervical decompression surgery:Anewmyelopathy
scale
Edward Kachur and Salem El-Zuway
McMaster University, Canada
C ervical Spondylotic Myelopathy (CSM) is the most common cause of spinal cord dysfunction in adults. Changes in
myelopathic signs following cervical decompression surgery and the relationship of the changes in myelopathic signs to
functional outcome remains unclear. We prospectively followed 36 patients pre-operatively and one year postoperatively and
examined changes in myelopathic signs and functional outcome and compared the relationship with each other. Functional
outcome was measured with the modified Japanese Orthopaedic Association (mJOA) scale and five myelopathic signs were
examined individually and collectively with our newly proposed myelopathic scale. The results and conclusions of these
findings will be discussed, as well as an outline of our new myelopathic scale.
Epilepsy in the Sudanese children and its impact on the growth parameters
Ebtihal Eltyeb
Omdurman Islamic University, Sudan
Background: Epilepsy has been suspected to affect the growth parameters in children who treated for longer time with
antiepileptic drugs.
Method: Unmatched case control study of 71 cases that were in long term treatment of epilepsy and 32 control cases.
Results: 36 (50.9%) of cases was found to be <3rd centile compared to 3 (10.9%) of the control group. Also 20 (30.9%) of cases
their height be <3rd compared to 1(3.6%) for the control. The mean weight of cases 27.3±8.1 kg, compared to 33.3±9.4 kg for
the control (P=0.000), as for the height the mean was 132.9±18.8 cm for the cases, compared to 139.7±11.6 cm for the control,
(P=0.017). No major difference in BMI the mean was 16.1±11 compared to 16.7± 2.7(P=0.67).
Conclusions: Epileptic children who are in long termmedications have affected growth parameters compared to their control.
Epilepsy may predispose to malnutrition. A better understanding of these interactions is necessary. Nutritional assessment is
still important as part of the comprehensive care of children with epilepsy.